Mineralys Therapeutics (MLYS) Stock Chart & Stock Price History $12.17 -0.28 (-2.25%) (As of 04:32 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Mineralys Therapeutics Stock Price Performance5 Day Performance-13.32%1 Month Performance-10.45%3 Month Performance+33.30%6 Month Performance-6.81%Year-To-Date Performance+41.51%1 Year Performance+70.21% Receive MLYS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Mineralys Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Genesis Gold GroupTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov MLYS Stock Chart for Thursday, November, 14, 2024 MLYS Chart by TradingView Mineralys Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/13/2024$13.38$12.45-6.95%$13.53$12.15242,098 shs$619.14 million11/12/2024$14.92$13.38-10.32%$14.73$13.00397,621 shs$665.39 million11/11/2024$14.04$14.92+6.27%$15.04$14.12342,504 shs$741.97 million11/08/2024$14.16$14.04-0.85%$14.52$13.70329,368 shs$698.21 million11/07/2024$14.95$14.16-5.28%$14.99$13.80658,690 shs$704.18 million11/06/2024$13.51$14.95+10.66%$15.25$13.61673,586 shs$671.31 million Get the Latest News and Ratings for MLYS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mineralys Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/05/2024$13.50$13.51+0.07%$13.70$13.33150,178 shs$671.85 million11/04/2024$13.45$13.50+0.37%$13.75$13.4195,622 shs$671.36 million11/01/2024$13.38$13.45+0.52%$13.74$13.11175,767 shs$668.87 million10/31/2024$13.78$13.38-2.90%$13.59$12.65162,481 shs$664.30 million10/30/2024$13.96$13.78-1.29%$13.96$13.60406,575 shs$684.16 million10/29/2024$13.89$13.96+0.50%$14.05$13.67150,136 shs$693.10 million10/28/2024$13.61$13.89+2.06%$14.01$13.6398,598 shs$690.75 million10/25/2024$13.60$13.61+0.07%$14.00$13.49117,217 shs$676.83 million10/24/2024$13.67$13.60-0.51%$13.79$13.3447,755 shs$675.23 million10/23/2024$13.95$13.67-2.01%$14.07$13.5639,537 shs$678.70 million10/22/2024$13.83$13.95+0.87%$13.95$13.6336,319 shs$692.60 million10/21/2024$14.40$13.83-3.96%$14.47$13.7841,642 shs$686.65 million10/18/2024$13.88$14.40+3.75%$14.44$13.68109,840 shs$714.95 million10/17/2024$13.94$13.88-0.43%$14.00$13.5578,675 shs$689.13 million10/16/2024$13.70$13.94+1.75%$13.95$13.50111,764 shs$692.11 million10/15/2024$13.59$13.70+0.81%$13.87$13.4265,103 shs$680.19 million10/14/2024$13.56$13.59+0.22%$13.64$13.3572,537 shs$674.73 million10/11/2024$13.42$13.56+1.04%$13.78$13.24145,251 shs$674.34 million10/10/2024$13.71$13.42-2.12%$13.85$13.40150,614 shs$666.29 million10/09/2024$13.60$13.71+0.81%$13.76$13.49116,826 shs$680.69 million10/08/2024$13.66$13.60-0.44%$13.92$13.41276,702 shs$675.23 million10/07/2024$13.88$13.66-1.59%$14.14$13.51272,518 shs$678.21 million10/04/2024$12.91$13.88+7.51%$13.92$12.80163,185 shs$689.13 million10/03/2024$12.80$12.91+0.86%$13.06$12.54133,786 shs$640.97 million10/02/2024$12.28$12.80+4.23%$12.90$11.90211,674 shs$635.51 million10/01/2024$12.11$12.28+1.40%$12.34$11.73129,338 shs$609.69 million09/30/2024$11.90$12.11+1.76%$12.17$11.7772,980 shs$601.25 million09/27/2024$11.99$11.90-0.75%$12.27$11.8097,441 shs$590.82 million09/26/2024$11.87$11.99+1.01%$12.13$11.7697,923 shs$596.26 million09/25/2024$11.70$11.87+1.45%$11.97$11.4884,980 shs$590.30 million09/24/2024$11.45$11.70+2.18%$11.73$11.2684,351 shs$580.89 million09/23/2024$11.71$11.45-2.22%$11.77$11.3373,365 shs$568.48 million09/20/2024$12.10$11.71-3.22%$12.10$11.59263,998 shs$581.39 million09/19/2024$11.69$12.10+3.51%$12.45$11.53281,277 shs$600.75 millionTrump’s Back, but DC’s Coming for Your Money! (Ad)Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov09/18/2024$11.98$11.69-2.42%$12.31$11.6972,497 shs$580.40 million09/17/2024$11.60$11.98+3.28%$12.22$11.5373,974 shs$594.80 million09/16/2024$11.76$11.60-1.36%$11.78$11.40152,480 shs$575.93 million09/13/2024$11.59$11.76+1.47%$12.19$11.47267,161 shs$583.87 million09/12/2024$11.64$11.59-0.43%$11.78$11.4982,584 shs$576.37 million09/11/2024$12.01$11.64-3.08%$12.24$11.5964,497 shs$578.86 million09/10/2024$11.84$12.01+1.44%$12.08$11.6558,078 shs$597.26 million09/09/2024$11.23$11.84+5.43%$12.06$11.1967,649 shs$588.80 million09/06/2024$11.94$11.23-5.95%$11.93$11.10101,807 shs$557.56 million09/05/2024$11.82$11.94+1.02%$12.08$11.7986,522 shs$592.81 million09/04/2024$11.95$11.82-1.09%$12.10$11.6158,654 shs$586.85 million09/03/2024$12.41$11.95-3.71%$12.99$11.8893,940 shs$594.27 million09/02/2024$12.41$12.41$12.84$12.16106,900 shs$617.15 million08/30/2024$12.57$12.41-1.27%$12.84$12.16106,900 shs$616.14 million08/29/2024$12.12$12.57+3.71%$12.78$12.0690,810 shs$624.09 million08/28/2024$12.20$12.12-0.66%$12.32$11.9865,003 shs$601.75 million08/27/2024$12.05$12.20+1.24%$12.50$11.85672,789 shs$605.72 million08/26/2024$11.61$12.05+3.79%$12.17$11.4486,924 shs$598.27 million08/23/2024$11.27$11.61+3.02%$11.66$11.24172,829 shs$576.43 million08/22/2024$11.14$11.27+1.17%$11.34$10.92145,985 shs$559.54 million08/21/2024$10.52$11.14+5.89%$11.30$10.58100,358 shs$553.09 million08/20/2024$10.62$10.52-0.94%$11.05$10.44153,077 shs$522.31 million08/19/2024$9.81$10.62+8.26%$10.69$9.80129,869 shs$527.27 million08/16/2024$9.76$9.81+0.51%$9.94$9.4990,070 shs$487.06 million08/15/2024$9.13$9.76+6.90%$9.93$8.85720,669 shs$484.57 million08/14/2024$11.83$9.13-22.82%$11.16$8.58670,407 shs$453.30 million08/13/2024$11.34$11.83+4.32%$11.88$11.31117,725 shs$587.35 million Related Companies AGIO Stock Chart VERA Stock Chart CPRX Stock Chart ARWR Stock Chart AMRX Stock Chart GERN Stock Chart AMPH Stock Chart IDYA Stock Chart ACAD Stock Chart RDY Stock Chart Receive MLYS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Mineralys Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MLYS) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredThis small cap’s electric marine powertrain broke the world speed recordThe future of marine propulsion has arrived-powered by a $2 billion powerhouse. In collaboration with McLar...The Tomorrow Investor | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredElon Musk has put himself in their crosshairsToday, I have another controversial prediction. One which I will take no pleasure in seeing come true. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mineralys Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mineralys Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MLYS Stock Alerts